Wilmer Cutler Pickering Hale and Dorr represented Telix Pharmaceuticals Limited in the transaction. Telix Pharmaceuticals Limited (ASX: TLX) (Telix), a biopharmaceutical company, announced its acquisition of...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Wonder Group in the transaction, and Wilmer Cutler Pickering Hale and Dorr represented Blue Apron Holdings. Wonder Group (“Wonder”) announced that it has...
You must be a Standard 1 Year member to access this content.
Arnold & Porter advised Coherus Biosciences Inc. on the deal, and Goodwin advised Surface Oncology. Coherus Biosciences Inc. (Coherus) announced its acquisition of Surface Oncology Inc. (Surface),...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Bessemer Venture Partners on the deal. Bessemer Venture Partners announced its acquisition of a majority stake in Litify. Bessemer partner Brian Feinstein will serve...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised CharterUP on the deal. CharterUP announced the completion of its $60 million in Series A. The financing round was led by Tritium Partners. CharterUP...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Apollo Intelligence on the deal. Apollo Intelligence announced its sale to Frazier Healthcare Partners. Apollo will continue to focus on elevating industry standards for...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Houghton Mifflin Harcourt on the deal while Milbank represented Veritas Capital. Houghton Mifflin Harcourt Company (HMH), a learning technology...
You must be a Standard 1 Year member to access this content.
Goodwin advised Enfusion on the deal, while Davis Polk advised the representatives of the several underwriters. Enfusion, Inc. completed its initial public offering of 21,562,500 shares...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised EQRx on the deal while White & Case LLP advised CM Life Sciences III Inc. EQRx, Inc. announced its definitive merger agreement with CM...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale, Dorr LLP and Skrine and Bär & Karrer advised The Tecan Group on the deal, while Schiff Hardin LLP represented Paramit Corporation....
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Roman DBDR, while Morgan, Lewis & Bockius LLP advised CompoSecure on the deal. Simpson Thacher served as counsel to the placement agents....
You must be a Standard 1 Year member to access this content.
